Related Experiment Video
Updated: Jun 25, 2026
06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
An electrochemical immunosensor based on antibody-nanowire conjugates
Georgios Pampalakis1, Shana O Kelley
1Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, CanadaM5S 3M2.
The Analyst
|February 25, 2009
Summary
Researchers developed gold nanowires for detecting prostate specific antigen (PSA). This electrochemical immunosensing method achieves high sensitivity for molecular and clinical diagnostics.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Analytical Chemistry
Background:
- Prostate specific antigen (PSA) is a key biomarker for prostate cancer diagnosis.
- Sensitive detection of PSA is crucial for early diagnosis and effective treatment monitoring.
- Current diagnostic methods face limitations in sensitivity and specificity.
Purpose of the Study:
- To develop and characterize gold nanowires for enhanced electrochemical immunosensing.
- To evaluate the performance of the functionalized gold nanowires in detecting PSA.
- To assess the suitability of the developed sensor for molecular and clinical diagnostics.
Main Methods:
- Synthesis and functionalization of gold nanowires.
- Fabrication of electrochemical immunosensors using modified electrodes.
- Electrochemical detection of varying concentrations of PSA.
Main Results:
- Successfully prepared gold nanowires with tailored surface properties.
- Demonstrated high sensitivity and specificity in PSA detection using the electrochemical immunosensor.
- Achieved detection limits meeting the requirements for clinical diagnostics.
Conclusions:
- The developed gold nanowire-based electrochemical immunosensor offers a promising platform for sensitive PSA detection.
- This technology has the potential to improve early prostate cancer diagnosis and patient management.
- Further validation in clinical settings is warranted.
